Cellink targets lab-on-a-chip applications with Nanoscribe acquisition
25 May 2021
Swedish bio-printing pioneer says it will gain a âleg upâ on competition with cash-plus-stock deal worth up to â¬50M.
Nanoscribe, the spin-out from the Karlsruhe Institute of Technology (KIT) that developed two-photon polymerization tools to make tiny, intricate structures, is set to become part of the fast-growing Swedish life sciences firm Cellink.
The two firms have agreed a cash-plus-stock deal that will see Cellink pay an initial â¬34 million for Nanoscribe, plus up to an additional â¬16 million in earn-outs if financial targets are met.
Assuming that the acquisition proceeds as expected, Nanoscribe will join forces with several other recent purchases made by Cellink, as the firm looks to build a portfolio of cutting-edge technologies that it believes will revolutionize biology and healthcare.
Visikol acquired by Sweden-based CELLINK for $7 5M roi-nj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from roi-nj.com Daily Mail and Mail on Sunday newspapers.
Product News: CELLINK launches an all-in-one imager and single-cell dispenser
UP.SIGHT™ is certified to help laboratories worldwide overcome major cell line development hurdles and improve efficiency across workflows
15 Mar 2021
cytena GmbH, a CELLINK company and leader in single cell dispensing technologies, launches the UP.SIGHT, a transformative single-cell dispensing system that increases efficiency in cell line development workflows. This all-in-one solution is equipped with cytena’s patented, fast and gentle single-cell dispensing technology and a rapid, high-quality imaging system that enables nozzle imaging and 3D Full Well Imaging (with no need for image stitching). It offers double assurance of clonality from two independent optical apparatuses and leads to a probability of clonality >99.99%.
Arctic15 Stockholm: 200 investors are coming! arcticstartup.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from arcticstartup.com Daily Mail and Mail on Sunday newspapers.
CELLINK launches the BIO MDX Series , a scaled-up revolution in biomedical manufacturing
STOCKHOLM, March 15, 2021 /PRNewswire/ CELLINK has announced the launch of the BIO MDX Series, the next generation of bioprinters designed for high-throughput biofabrication and precision 3D bioprinting for biomedical manufacturing, including biocompatible medical devices. Over the past 5 years, as bioprinting has increasingly become the method of choice for researchers in tissue engineering, cell culturing and regenerative medicine, there has been a greater need for improved automation, precision, and reproducibility across fabrication methods. With up to six printheads, nanoliter and picoliter dispensing channels and easy robotic integration, the BIO MDX and BIO MDX+ bioprinters have been specifically designed to meet the demands of the ever-advancing cell-based technologies.